type,message,urgency,timestamp,period,decision_context
monitoring,The FDA is closely monitoring the emerging shortage situation. We encourage manufacturers and healthcare providers to report supply issues and collaborate on solutions to ensure patient needs are met.,elevated,2025-07-25T12:02:54.329651,1,"{'shortage_assessment': 'The shortage is emerging with insufficient supply and volatile market stability, requiring close observation.', 'intervention_justification': 'A monitoring statement is suitable as the situation does not yet meet the threshold for a formal alert, but coordination could preempt further issues.', 'market_impact_prediction': 'Manufacturers may begin to assess capacity expansion, while buyers are less likely to panic buy due to the non-alarmist nature of the message.', 'patient_safety_considerations': 'The current patient safety risk is low, allowing for a measured approach to avoid unnecessary market disruptions.'}"
